OMALIZUMAB FOR CHILDREN WITH BRONCHIAL ASTHMA: INDICATIONS TO APPLICATION
Antibodies to IgE are a totally new class of medications currently used to enhance the supervision over severe persistent atopic bronchial asthma. Omalizumab is the most well studied, first and only medication of this group, which is recommended for the application and is allowed for treatment of un...
| Автор: | |
|---|---|
| Формат: | Стаття |
| Мова: | Russian |
| Опубліковано: |
Union of pediatricians of Russia
2007-12-01
|
| Серія: | Педиатрическая фармакология |
| Онлайн доступ: | https://www.pedpharma.ru/jour/article/view/689 |